PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 15, 2026Expert Review of Pharmacoeconomics & Outcomes Research0 citations

Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study

View Full Paper
RRRegina Rendas‐BaumJBJakob BjornerVPVíctor Preckler

Key Points

  • The study aims to obtain RSV-related health utility values for older adults and caregivers in Japan.
  • Conducted a cross-sectional, observational study among Japanese adults (≥18 years) from April to June 2023
  • Participants completed an online survey describing RSV-related health states using six vignettes
  • Utilized a time trade-off approach to quantify QALY losses for patients and caregivers.
  • Median discounted TTO values were 73, 22, and 7 days for severe lower respiratory tract infection, lower respiratory tract infection, and upper respiratory tract infection, respectively
  • QALY losses were 0.200, 0.060, and 0.018 for patients and 0.086, 0.043, and 0.008 for caregivers
  • 241 participants were analyzed after excluding 1,529 from a total of 1,770.

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is a common virus affecting the respiratory system in all ages. The study's objective was to obtain RSV-related health utility values for older adults and their caregivers from the Japanese population. RESEARCH DESIGN AND METHODS: A cross-sectional, observational study was conducted among Japanese adults (≥18 years) between April - June 2023 to quantify the burden of RSV. Participants completed an online survey with six vignettes describing RSV-related health states for patients and caregivers: severe lower respiratory tract infection (sLRTI), lower respiratory tract infection (LRTI), and upper respiratory tract infection (URTI). Using a time trade-off (TTO) approach, respondents indicated the number of days they would trade to avoid these health states. Quality-adjusted life-year (QALY) losses were then estimated. RESULTS: Of 1,770 participants, 1,529 were excluded, leaving 241 for analysis (45 with caregiving experience). Median discounted TTO values were 73, 22, and 7 days for sLRTI, LRTI, and URTI, respectively, and 31, 16, and 3 days to avoid caregiving burden. QALY losses were 0.200, 0.060, and 0.018 for patients and 0.086, 0.043, and 0.008 for caregivers. CONCLUSIONS: Japanese individuals are willing to trade a significant number of days from the end of their life to avoid an RSV episode or its caregiver burden.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rendas‐Baum et al. (2026) studied this question.

synapsesocial.com/papers/6a06b983e7dec685947ac451https://doi.org/10.1080/14737167.2026.2671770
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis2024 · 13 citations
  2. 2Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands2012 · 47 citations
  3. 3Community and Patient Values for Preventing Herpes Zoster2008 · 44 citations
  4. 4Generalized Linear Models1989 · 16,887 citations
  5. 5Measuring and Valuing Health Benefits for Economic Evaluation2016 · 1,065 citations